Glukose B. Braun (Glucose, Anhydrous)

Glukose B. Braun is a parenteral preparation containing glucose (anhydrous) as the sole active ingredient. It is supplied in a sterile solution for intramuscular, intravenous, or subcutaneous administration. The product is manufactured in the European Union and is classified as an excipient rather than a therapeutic drug. Glukose B. Braun provides a readily available source of carbohydrate for clinical use. It is used in hospital and outpatient settings.

Glukose B. Braun is employed in clinical practice where a rapid source of carbohydrate is required. It can be administered intravenously, subcutaneously, or intramuscularly depending on the clinical situation.

- Treatment of hypoglycemia when oral glucose is not feasible. - Provision of calories during parenteral nutrition. - Diluent or carrier for other intravenous medications. - Fluid replacement in patients needing both volume and glucose. - Support during diagnostic procedures that require glucose infusion.

Side effects of Glukose B. Braun are generally related to its osmolarity and glucose content. Most reactions are mild, but serious events can occur in susceptible individuals.

Common: - Local irritation at the injection site. - Mild hyperglycemia. - Nausea or vomiting. - Headache. - Transient electrolyte shifts.

Serious: - Severe hyperglycemia leading to ketoacidosis. - Fluid overload or pulmonary edema. - Allergic reaction or anaphylaxis. - Severe electrolyte imbalance (e.g., hyponatremia).

When using Glukose B. Braun, clinicians should consider patient-specific factors and monitor for potential complications.

- Assess blood glucose levels before and after administration. - Use caution in patients with diabetes, renal impairment, or heart failure. - Monitor fluid balance to avoid overload. - Adjust dosage in pediatric or geriatric populations. - Ensure proper aseptic technique to prevent infection. - Discontinue if signs of allergic reaction develop.

Glukose B. Braun may interact with other medications that affect glucose metabolism or fluid balance. Awareness of these interactions helps prevent adverse outcomes.

Avoid: - Concurrent high-dose insulin without glucose monitoring. - Medications that cause severe hypoglycemia (e.g., sulfonylureas) without appropriate glucose supplementation.

Use with caution: - Beta‑blockers, which may mask hypoglycemia symptoms. - Diuretics that can alter electrolyte status. - Corticosteroids, which may increase blood glucose levels. - Cardiovascular drugs that affect fluid status (e.g., ACE inhibitors).